| Year |
Citation |
Score |
| 2020 |
Kunjachan S, Detappe A, Kumar R, Ireland T, Cameron L, Biancur DE, Motto-Ros V, Sancey L, Sridhar S, Makrigiorgos GM, Berbeco RI. Correction to "Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy". Nano Letters. PMID 32787156 DOI: 10.1021/Acs.Nanolett.0C03032 |
0.308 |
|
| 2020 |
Mueller R, Yasmin-Karim S, DeCosmo K, Vazquez-Pagan A, Sridhar S, Kozono D, Hesser J, Ngwa W. Increased carcinoembryonic antigen expression on the surface of lung cancer cells using gold nanoparticles during radiotherapy. Physica Medica : Pm : An International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (Aifb). 76: 236-242. PMID 32731132 DOI: 10.1016/J.Ejmp.2020.06.024 |
0.31 |
|
| 2020 |
Virani NA, Kelada OJ, Kunjachan S, Detappe A, Kwon J, Hayashi J, Vazquez-Pagan A, Biancur DE, Ireland T, Kumar R, Sridhar S, Makrigiorgos GM, Berbeco RI. Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption. Plos One. 15: e0236245. PMID 32706818 DOI: 10.1371/Journal.Pone.0236245 |
0.325 |
|
| 2020 |
Schuemann J, Bagley A, Berbeco R, Bromma K, Butterworth KT, Byrne H, Chithrani DB, Cho SH, Cook JR, Favaudon V, Gholami YH, Gargioni E, Hainfeld JF, Hespeels F, Heuskin AC, ... ... Sridhar S, et al. Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Physics in Medicine and Biology. PMID 32380492 DOI: 10.1088/1361-6560/Ab9159 |
0.343 |
|
| 2020 |
Cheng MJ, Mitra R, Okorafor CC, Nersesyan AA, Harding IC, Bal NN, Kumar R, Jo H, Sridhar S, Ebong EE. Targeted Intravenous Nanoparticle Delivery: Role of Flow and Endothelial Glycocalyx Integrity. Annals of Biomedical Engineering. PMID 32072383 DOI: 10.1007/S10439-020-02474-4 |
0.324 |
|
| 2019 |
Kunjachan S, Kotb S, Pola R, Pechar M, Kumar R, Singh B, Gremse F, Taleeli R, Trichard F, Motto-Ros V, Sancey L, Detappe A, Yasmin-Karim S, Protti A, Shanmugam I, ... ... Sridhar S, et al. Selective Priming of Tumor Blood Vessels by Radiation Therapy Enhances Nanodrug Delivery. Scientific Reports. 9: 15844. PMID 31676822 DOI: 10.1038/S41598-019-50538-W |
0.329 |
|
| 2019 |
Zhang D, Baldwin P, Leal AS, Carapellucci S, Sridhar S, Liby KT. A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice. Theranostics. 9: 6224-6238. PMID 31534547 DOI: 10.7150/Thno.36281 |
0.303 |
|
| 2019 |
Baldwin P, Ohman AW, Medina JE, McCarthy ET, Dinulescu DM, Sridhar S. Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model. Frontiers in Oncology. 9: 353. PMID 31134152 DOI: 10.3389/Fonc.2019.00353 |
0.339 |
|
| 2019 |
Kelada OJ, Kunjachan S, Virani NA, Detappe A, Hayashi J, Ireland T, Biancur DE, Kumar R, Sridhar S, Makrigiorgos M, Berbeco RI. Abstract 85: Noninvasive imaging of tumor hypoxia during radiation-induced tumor vascular disruption Cancer Research. 79: 85-85. DOI: 10.1158/1538-7445.Sabcs18-85 |
0.312 |
|
| 2019 |
Singh B, Abdelhalim M, Warrington S, Sridhar S. Abstract 3631: Development of targeted nanoformulation of talazoparib for combined chemoradiation therapy in lung cancer Cancer Research. 79: 3631-3631. DOI: 10.1158/1538-7445.Sabcs18-3631 |
0.37 |
|
| 2019 |
Baldwin P, Orriols A, Sridhar S. Abstract 3642: Combination nanotherapy using the PARP inhibitor talazoparib and cyclin dependent kinase inhibitor dinaciclib Cancer Research. 79: 3642-3642. DOI: 10.1158/1538-7445.Am2019-3642 |
0.324 |
|
| 2019 |
Singh B, Yang S, Baldwin P, Ven Avd, Sridhar S. Abstract A104: Nanoformulations of PARP and CDK inhibitors for cancer therapy Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-A104 |
0.301 |
|
| 2018 |
Baldwin P, Ohman AW, Tangutoori S, Dinulescu DM, Sridhar S. Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment. International Journal of Nanomedicine. 13: 8063-8074. PMID 30555227 DOI: 10.2147/Ijn.S186881 |
0.334 |
|
| 2018 |
Guthier CV, D'Amico AV, King MT, Nguyen PL, Orio PF, Sridhar S, Makrigiorgos GM, Cormack RA. Determining Optimal Eluter Design by Modeling Physical Dose Enhancement in Brachytherapy. Medical Physics. PMID 29905964 DOI: 10.1002/Mp.13051 |
0.367 |
|
| 2018 |
Upponi JR, Jerajani K, Nagesha DK, Kulkarni P, Sridhar S, Ferris C, Torchilin VP. Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents. Biomaterials. 170: 26-36. PMID 29649747 DOI: 10.1016/J.Biomaterials.2018.03.054 |
0.718 |
|
| 2018 |
Baronia R, Singh M, Gupta RB, Karuppiah S, Kumar R, Belz J, Shanker R, Sridhar S, Singh SP. Synthesis and characterization of multifunctional gold nanoclusters for application in radiation therapy. International Journal of Nanomedicine. 13: 113-115. PMID 29593408 DOI: 10.2147/Ijn.S125006 |
0.319 |
|
| 2018 |
Gupta P, Singh M, Kumar R, Belz J, Shanker R, Dwivedi PD, Sridhar S, Singh SP. Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer. International Journal of Nanomedicine. 13: 67-69. PMID 29593398 DOI: 10.2147/Ijn.S124995 |
0.402 |
|
| 2018 |
Cheng MJ, Prabakaran P, Kumar R, Sridhar S, Ebong EE. Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery. Journal of Visualized Experiments : Jove. PMID 29364277 DOI: 10.3791/56760 |
0.365 |
|
| 2018 |
Baldwin P, Kumar R, Sridhar S. Abstract 3715: Targeted nanotherapy using the PARP inhibitor talazoparib for breast cancer treatment Cancer Research. 78: 3715-3715. DOI: 10.1158/1538-7445.Am2018-3715 |
0.34 |
|
| 2018 |
Vazquez-Pagan AG, Baldwin P, Ashtaputre RM, Kunjachan S, Sridhar S, Kumar R, Berbeco R. Abstract 3710: Nanoparticle-mediated concomitant radiation dose amplification and PARP inhibition in lung cancer Cancer Research. 78: 3710-3710. DOI: 10.1158/1538-7445.Am2018-3710 |
0.321 |
|
| 2017 |
Belz JE, Kumar R, Baldwin P, Ojo NC, Leal AS, Royce DB, Zhang D, van de Ven AL, Liby KT, Sridhar S. Sustained Release Talazoparib Implants for Localized Treatment of BRCA1-deficient Breast Cancer. Theranostics. 7: 4340-4349. PMID 29158830 DOI: 10.7150/Thno.18563 |
0.332 |
|
| 2017 |
Hachani R, Birchall MA, Lowdell MW, Kasparis G, Tung LD, Manshian BB, Soenen SJ, Gsell W, Himmelreich U, Gharagouzloo CA, Sridhar S, Thanh NTK. Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging. Scientific Reports. 7: 7850. PMID 28798327 DOI: 10.1038/S41598-017-08092-W |
0.359 |
|
| 2017 |
van de Ven AL, Tangutoori S, Baldwin P, Qiao J, Gharagouzloo C, Seitzer N, Clohessy JG, Makrigiorgos GM, Cormack R, Pandolfi PP, Sridhar S. Nanoformulation of Olaparib amplifies PARP inhibition and sensitizes PTEN/TP53-deficient prostate cancer to radiation. Molecular Cancer Therapeutics. PMID 28500233 DOI: 10.1158/1535-7163.Mct-16-0740 |
0.319 |
|
| 2017 |
Belz J, Castilla-Ojo N, Sridhar S, Kumar R. Radiosensitizing Silica Nanoparticles Encapsulating Docetaxel for Treatment of Prostate Cancer. Methods in Molecular Biology (Clifton, N.J.). 1530: 403-409. PMID 28150218 DOI: 10.1007/978-1-4939-6646-2_26 |
0.394 |
|
| 2017 |
Baldwin P, Ohman A, Dinulescu D, Sridhar S. Abstract NTOC-080: NANOOLAPARIB: AN INTRAPERITONEAL PARP INHIBITOR THERAPY FOR OVARIAN CANCER Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Ntoc-080 |
0.359 |
|
| 2017 |
Ven ALvd, Tangutoori S, Baldwin P, Qiao J, Gharagouzloo C, Seitzer N, Clohessy J, Korideck H, Makrigiorgos GM, Cormack R, Pandolfi PP, Sridhar S. Abstract B48: Prostate cancer pre-treatment with nanoformulated Olaparib overcomes radiation resistance Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B48 |
0.338 |
|
| 2017 |
Paro AD, Shanmugam I, Ven Avd, Kumar R, Webster TJ, Sridhar S. Abstract B44: Biological mechanisms involved in nanoparticle-enhanced radiation therapy for pancreatic cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B44 |
0.34 |
|
| 2017 |
Kumar R, Ngwa W, Joshi V, Kunjachan S, Berbeco R, Makrigiorgos M, Sridhar S. Abstract B41: Gold nanoparticles based platforms for localized radiosensitization in cancer radiation therapy Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B41 |
0.323 |
|
| 2017 |
Belz J, Ojo NC, Baldwin P, Kumar R, Ven Avd, Liby K, Cormack R, Makrigiorgos M, Sridhar S. Abstract B30: Sustained release of PARP inhibitor Talazoparib and chemotherapeutic Docetaxel from modified brachytherapy spacers for treatment of breast and prostate cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B30 |
0.337 |
|
| 2017 |
Baldwin P, Ohman A, Belz J, Thong J, Ojo NC, Liby K, Dinulescu D, Sridhar S. Abstract B29: Nanoformulations and sustained delivery systems for the PARP inhibitors Olaparib and Talazoparib Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B29 |
0.363 |
|
| 2017 |
Codi G, Qiao J, Timms L, Ven Avd, Sridhar S. Abstract B22: Quantitative tumor imaging using magnetic nanoparticles Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B22 |
0.346 |
|
| 2017 |
Baldwin P, Kumar R, Favours E, Liby K, Kurmasheva R, Kozono D, Sridhar S. Abstract 3100: Nanoformulated Talazoparib and Olaparib for enhanced delivery Cancer Research. 77: 3100-3100. DOI: 10.1158/1538-7445.Am2017-3100 |
0.377 |
|
| 2016 |
Belz J, Kumar R, Makrigiorgos G, D'Amico A, Nguyen P, Cormack R, Sridhar S. WE-FG-BRA-02: Docetaxel Eluting Brachytherapy Spacers for Local Chemo-Radiation Therapy in Prostate Cancer. Medical Physics. 43: 3823. PMID 28046887 DOI: 10.1118/1.4957902 |
0.301 |
|
| 2016 |
Geilich BM, Gelfat I, Sridhar S, van de Ven AL, Webster TJ. Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication. Biomaterials. 119: 78-85. PMID 28011336 DOI: 10.1016/J.Biomaterials.2016.12.011 |
0.302 |
|
| 2016 |
Cormack RA, Nguyen PL, D'Amico AV, Sridhar S, Makrigiorgos M. In Situ Radiosensitization of Brachytherapy: Image Guided Planned Biologic Enhancement of Brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 96: E649. PMID 27675258 DOI: 10.1016/J.Ijrobp.2016.06.2253 |
0.301 |
|
| 2016 |
Cheng MJ, Kumar R, Sridhar S, Webster TJ, Ebong EE. Endothelial glycocalyx conditions influence nanoparticle uptake for passive targeting. International Journal of Nanomedicine. 11: 3305-15. PMID 27499624 DOI: 10.2147/Ijn.S106299 |
0.329 |
|
| 2016 |
Markovic S, Belz J, Kumar R, Cormack RA, Sridhar S, Niedre M. Near-infrared fluorescence imaging platform for quantifying in vivo nanoparticle diffusion from drug loaded implants. International Journal of Nanomedicine. 11: 1213-23. PMID 27069363 DOI: 10.2147/Ijn.S93324 |
0.375 |
|
| 2016 |
Schuemann J, Berbeco R, Chithrani DB, Cho SH, Kumar R, McMahon SJ, Sridhar S, Krishnan S. Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization. International Journal of Radiation Oncology, Biology, Physics. 94: 189-205. PMID 26700713 DOI: 10.1016/J.Ijrobp.2015.09.032 |
0.315 |
|
| 2016 |
Baldwin P, Ohman A, Thong J, Tangutoori S, Dinulescu D, Sridhar S. Abstract A03: PARP inhibitor nanotherapy for ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A03 |
0.308 |
|
| 2016 |
Baldwin P, Ohman A, Thong J, Tangutoori S, Ven Avd, Kumar R, Dinulescu D, Sridhar S. Abstract 4335: Nanoformulations of PARP inhibitors Olaparib and Talazoparib for targeted cancer therapy Cancer Research. 76: 4335-4335. DOI: 10.1158/1538-7445.Am2016-4335 |
0.336 |
|
| 2016 |
Belz J, Ojo NC, Baldwin P, Kumar R, Ven Avd, Liby K, Cormack R, Makrigiorgos M, Sridhar S. Abstract 3900: Sustained release of PARP inhibitor Talazoparib and chemotherapeutics from biodegradable implants for treatment of breast and prostate cancer Cancer Research. 76: 3900-3900. DOI: 10.1158/1538-7445.Am2016-3900 |
0.342 |
|
| 2016 |
Kunjachan S, Detappe A, Kumar R, Sridhar S, Makrigiorgos GM, Berbeco R. PO-0983: Nanoparticle mediated tumor vascular disruption: A novel strategy in radiation therapy Radiotherapy and Oncology. 119. DOI: 10.1016/S0167-8140(16)32233-2 |
0.309 |
|
| 2015 |
Kunjachan S, Detappe A, Kumar R, Ireland T, Cameron L, Biancur DE, Motto-Ros V, Sancey L, Sridhar S, Makrigiorgos GM, Berbeco RI. Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy. Nano Letters. PMID 26418302 DOI: 10.1021/Acs.Nanolett.5B03073 |
0.332 |
|
| 2015 |
Cifter G, Sajo E, Korideck H, Kumar R, Sridhar S, Cormack R, Makrigiorgos G, Ngwa W. MO-FG-BRA-05: Next Generation Radiotherapy Biomaterials Loaded With Gold Nanoparticles. Medical Physics. 42: 3565. PMID 26128708 DOI: 10.1118/1.4925409 |
0.345 |
|
| 2015 |
Kumar R, Belz J, Markovic S, Jadhav T, Fowle W, Niedre M, Cormack R, Makrigiorgos MG, Sridhar S. Nanoparticle-based brachytherapy spacers for delivery of localized combined chemoradiation therapy. International Journal of Radiation Oncology, Biology, Physics. 91: 393-400. PMID 25636762 DOI: 10.1016/J.Ijrobp.2014.10.041 |
0.327 |
|
| 2015 |
Sinha N, Cifter G, Sajo E, Kumar R, Sridhar S, Nguyen PL, Cormack RA, Makrigiorgos GM, Ngwa W. Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters. International Journal of Radiation Oncology, Biology, Physics. 91: 385-92. PMID 25482302 DOI: 10.1016/J.Ijrobp.2014.10.001 |
0.361 |
|
| 2015 |
Wang H, Kumar R, Nagesha D, Duclos RI, Sridhar S, Gatley SJ. Integrity of (111)In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse. Nuclear Medicine and Biology. 42: 65-70. PMID 25277378 DOI: 10.1016/J.Nucmedbio.2014.08.014 |
0.697 |
|
| 2015 |
Gharagouzloo CA, McMahon PN, Sridhar S. Quantitative contrast-enhanced MRI with superparamagnetic nanoparticles using ultrashort time-to-echo pulse sequences. Magnetic Resonance in Medicine. 74: 431-41. PMID 25168606 DOI: 10.1002/Mrm.25426 |
0.312 |
|
| 2015 |
Tangutoori S, Baldwin P, Medina J, Ohman A, Dinulescu D, Sridhar S. Abstract AS29: PARP inhibitor nano-therapy in ovarian cancer models Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-As29 |
0.339 |
|
| 2015 |
Kumar R, Belz J, Shanmugam I, Ngwa W, Berbeco R, Makrigiorgos M, Sridhar S. Abstract C147: Radiosensitization using gold nanoparticles for effectively targeting molecular pathways in cancer radiation therapy Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C147 |
0.38 |
|
| 2015 |
Belz J, Liby K, Baldwin P, Kumar R, Ven ALvd, Cormack R, Makrigiorgos M, Sridhar S. Abstract B42: Sustained release of PARP inhibitor Talazoparib from bioedgradable implant for treatment of BRCA1-mutated breast cancer Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B42 |
0.318 |
|
| 2015 |
Baldwin P, Shanmugam I, Tangutoori S, Ohman A, Dinulescu D, Cormack R, Makrigiorgos M, Sridhar S. Abstract B35: Nanoformulations of PAPR inhibitors nanoolaparib and nanotalazoparib for targeted cancer therapy Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B35 |
0.322 |
|
| 2014 |
Cormack R, Ngwa W, Tangutoori S, Rajiv K, Sridhar S, Makrigiorgos G. SU-F-19A-08: Optimal Time Release Schedule of In-Situ Drug Release During Permanent Prostate Brachytherapy. Medical Physics. 41: 389-390. PMID 28036433 DOI: 10.1118/1.4889034 |
0.334 |
|
| 2014 |
Ngwa W, Kumar R, Sridhar S, Korideck H, Zygmanski P, Cormack RA, Berbeco R, Makrigiorgos GM. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (London, England). 9: 1063-82. PMID 24978464 DOI: 10.2217/Nnm.14.55 |
0.328 |
|
| 2014 |
Navarro G, Essex S, Sawant RR, Biswas S, Nagesha D, Sridhar S, de ILarduya CT, Torchilin VP. Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 411-9. PMID 23928214 DOI: 10.1016/J.Nano.2013.07.016 |
0.666 |
|
| 2014 |
Kumar R, Belz J, Markovic S, Niedre M, Ngwa W, Korideck H, Cormack R, Nguyen P, D'Amico A, Makrigiorgos M, Sridhar S. Abstract 4917: Smart brachytherapy spacers eluting nanoencapsulated radiosensitizers for chemo-radiation therapy Cancer Research. 74: 4917-4917. DOI: 10.1158/1538-7445.Am2014-4917 |
0.409 |
|
| 2014 |
Tangutoori S, Baldwin P, Korideck H, Cormack R, Makrigiorgos MG, Sridhar S. Abstract 2397: Nanoformulations of PARP inhibtors for cancer therapy Cancer Research. 74: 2397-2397. DOI: 10.1158/1538-7445.Am2014-2397 |
0.336 |
|
| 2014 |
Berbeco R, Korideck H, Kumar R, Sridhar S, Makrigiorgos M. 20: Targeted Gold Nanoparticles as Vascular Disrupting Agents during Radiotherapy Radiotherapy and Oncology. 110. DOI: 10.1016/S0167-8140(15)34041-X |
0.344 |
|
| 2014 |
Berbeco R, Korideck H, Kumar R, Sridhar S, Detappe A, Ngwa W, Makrigiorgos M. Targeted Gold Nanoparticles as Vascular Disrupting Agents During Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 90: S198. DOI: 10.1016/J.Ijrobp.2014.05.743 |
0.313 |
|
| 2013 |
Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H, Meade T, Pomper M, Ptak K, Rao J, Singh R, Sridhar S, Stern S, Wang A, Weaver JB, et al. Nanoparticles for cancer imaging: The good, the bad, and the promise. Nano Today. 8: 454-460. PMID 25419228 DOI: 10.1016/J.Nantod.2013.06.001 |
0.374 |
|
| 2013 |
Kumar R, Korideck H, Ngwa W, Berbeco RI, Makrigiorgos GM, Sridhar S. Third generation gold nanoplatform optimized for radiation therapy. Translational Cancer Research. 2. PMID 24392307 DOI: 10.3978/J.Issn.2218-676X.2013.07.02 |
0.375 |
|
| 2013 |
Kumar R, Kulkarni A, Nabulsi J, Nagesha DK, Cormack R, Makrigiorgos MG, Sridhar S. Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle. Drug Delivery and Translational Research. 3: 299-308. PMID 23914343 DOI: 10.1007/S13346-012-0124-9 |
0.728 |
|
| 2013 |
Rivera-Chacon DM, Alvarado-Velez M, Acevedo-Morantes CY, Singh SP, Gultepe E, Nagesha D, Sridhar S, Ramirez-Vick JE. Fibronectin and vitronectin promote human fetal osteoblast cell attachment and proliferation on nanoporous titanium surfaces. Journal of Biomedical Nanotechnology. 9: 1092-7. PMID 23858975 DOI: 10.1166/Jbn.2013.1601 |
0.751 |
|
| 2013 |
Ngwa W, Korideck H, Kassis AI, Kumar R, Sridhar S, Makrigiorgos GM, Cormack RA. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine : Nanotechnology, Biology, and Medicine. 9: 25-7. PMID 23041410 DOI: 10.1016/J.Nano.2012.09.001 |
0.301 |
|
| 2013 |
Gharagouzloo C, Jillela M, Kumar R, Nagesha D, Sridhar S. Abstract 2673: Positive contrast imaging of magnetic nanoplatforms for image-guided drug delivery. Cancer Research. 73: 2673-2673. DOI: 10.1158/1538-7445.Am2013-2673 |
0.738 |
|
| 2013 |
Kumar R, Belz J, Markovic S, Jadhav T, Nguyen P, Niedre M, DAmico A, Makrigiorgos M, Cormack R, Sridhar S. Abstract 1594: Sustained release of drug eluting nanoparticles from implantable devices for loco-regional chemoradiation therapy. Cancer Research. 73: 1594-1594. DOI: 10.1158/1538-7445.Am2013-1594 |
0.417 |
|
| 2013 |
Kumar R, Belz JE, Markovic S, Korideck H, Ngwa WF, Niedre M, Berbeco RI, Cormack R, Makrigiorgos MG, Sridhar S. Abstract A82: Localized tumor delivery of radiosensitizers and chemotherapeutics using ‘INCeRT’ implants. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A82 |
0.423 |
|
| 2013 |
Tangutoori S, Korideck H, Makrigiorgos M, Cormack R, Sridhar S. Abstract A81: A novel nano-formulation for systemic administration of PARPi-olaparib (Nano-Olaparib) for radiosensitization, chemosensitization, and combinatorial therapy in prostate cancer. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A81 |
0.371 |
|
| 2013 |
Faegh S, Jalili N, Yavuzcetin O, Nagesha D, Kumar R, Sridhar S. A cost-effective self-sensing biosensor for detection of biological species at ultralow concentrations Journal of Applied Physics. 113. DOI: 10.1063/1.4807832 |
0.669 |
|
| 2012 |
Berbeco RI, Korideck H, Ngwa W, Kumar R, Patel J, Sridhar S, Johnson S, Price BD, Kimmelman A, Makrigiorgos GM. DNA damage enhancement from gold nanoparticles for clinical MV photon beams. Radiation Research. 178: 604-8. PMID 23148509 DOI: 10.1667/Rr3001.1 |
0.315 |
|
| 2012 |
Kumar R, Kulkarni A, Nagesha DK, Sridhar S. In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer. Theranostics. 2: 714-22. PMID 22896773 DOI: 10.7150/Thno.3927 |
0.723 |
|
| 2012 |
Kumar R, Kulkarni A, Nagesha D, Cormack R, Makrigiorgos M, Sridhar S. Abstract 1473: Nanocoated brachytherapy spacers eluting radiosensitizers for biological in situ image-guided radiation therapy of prostate cancer Cancer Research. 72: 1473-1473. DOI: 10.1158/1538-7445.Am2012-1473 |
0.72 |
|
| 2012 |
Kumar R, Patel J, Korideck H, Berbeco RI, Makrigiorgos MG, Sridhar S. Abstract 1472: Comprehensive evaluation of PEGylated gold nanorods for two photon photoluminescence image guided radiation therapy enhancement Cancer Research. 72: 1472-1472. DOI: 10.1158/1538-7445.Am2012-1472 |
0.388 |
|
| 2012 |
Berbeco R, Korideck H, Ngwa W, Kumar R, Patel J, Sridhar S, Johnson S, Price B, Kimmelman A, Makrigiorgos M. TU-C-BRB-11: In Vitro Dose Enhancement from Gold Nanoparticles under Different Clinical MV Photon Beam Configurations Medical Physics. 39: 3900-3901. DOI: 10.1118/1.4735923 |
0.315 |
|
| 2012 |
Cormack R, Nguyen P, D'Amico AV, Sridhar S, Makrigiorgos GM. Locally Drug Enhanced Brachytherapy: A Comparison of 2 Approaches Based on Biologically Effective Dose International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.2285 |
0.305 |
|
| 2011 |
Sridhar S, Campbell R, Nagesha D, Gultepe E. Abstract 380: Magnetic nanoplatforms for tumor targeting, imaging and energy delivery Cancer Research. 71: 380-380. DOI: 10.1158/1538-7445.Am2011-380 |
0.784 |
|
| 2011 |
Sridhar S, Nagesha D, Tada D, Kumar R, Makrigiorgos GM, Cormack R. Abstract 2674: Radio-sensitizer eluting nanoporous coatings on fiducials markers: Biological in-situ dose-painting for IGRT Cancer Research. 71: 2674-2674. DOI: 10.1158/1538-7445.Am2011-2674 |
0.719 |
|
| 2011 |
Casse BDF, Huang YJ, Lu WT, Gultepe E, Menon L, Sridhar S. Beating the diffraction limit using a 3D nanowires metamaterials nanolens Proceedings of Spie. 8034: 803407. DOI: 10.1117/12.883699 |
0.727 |
|
| 2010 |
Gultepe E, Reynoso FJ, Jhaveri A, Kulkarni P, Nagesha D, Ferris C, Harisinghani M, Campbell RB, Sridhar S. Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution. Nanomedicine (London, England). 5: 1173-82. PMID 21039195 DOI: 10.2217/Nnm.10.84 |
0.784 |
|
| 2010 |
Nagesha DK, Tada DB, Stambaugh CK, Gultepe E, Jost E, Levy CO, Cormack R, Makrigiorgos GM, Sridhar S. Radiosensitizer-eluting nanocoatings on gold fiducials for biological in-situ image-guided radio therapy (BIS-IGRT). Physics in Medicine and Biology. 55: 6039-52. PMID 20858923 DOI: 10.1088/0031-9155/55/20/001 |
0.792 |
|
| 2010 |
Tada DB, Singh S, Nagesha D, Jost E, Levy CO, Gultepe E, Cormack R, Makrigiorgos GM, Sridhar S. Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release. Pharmaceutical Research. 27: 1738-45. PMID 20521086 DOI: 10.1007/S11095-010-0176-9 |
0.778 |
|
| 2010 |
Gultepe E, Nagesha D, Casse BD, Banyal R, Fitchorov T, Karma A, Amiji M, Sridhar S. Sustained drug release from non-eroding nanoporous templates. Small (Weinheim An Der Bergstrasse, Germany). 6: 213-6. PMID 19967712 DOI: 10.1002/Smll.200901736 |
0.771 |
|
| 2010 |
Gultepe E, Nagesha D, Sridhar S, Amiji M. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Advanced Drug Delivery Reviews. 62: 305-15. PMID 19922749 DOI: 10.1016/J.Addr.2009.11.003 |
0.77 |
|
| 2010 |
Cormack RA, Sridhar S, Suh WW, D'Amico AV, Makrigiorgos GM. Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices. International Journal of Radiation Oncology, Biology, Physics. 76: 615-23. PMID 19879699 DOI: 10.1016/J.Ijrobp.2009.06.039 |
0.365 |
|
| 2010 |
Casse BD, Lu WT, Huang Y, Gultepe E, Menon L, Sridhar S. Beating the diffraction limit using a 3D nanowires metamaterials nanolens Frontiers in Optics. DOI: 10.1364/Fio.2010.Fwo3 |
0.761 |
|
| 2010 |
Reynoso F, Gultepe E, Jhaveri A, Kulkarni P, Gershman B, Ferris C, Campbell R, Harisinghani M, Sridhar S. TH-D-201C-08: Multi-Modal MRI SPECT and CT Imaging of Theranostic Nanoplatforms Medical Physics. 37: 3470-3470. DOI: 10.1118/1.3469556 |
0.75 |
|
| 2010 |
Stambaugh C, Tada D, Nagesha D, Jost E, Levy C, Cormack R, Makrigiorgos M, Sridhar S. WE-E-204B-02: Release Kinetics of Radio-Sensitizers from Nanoporous Coatings on Gold Fiducials: Biological In-Situ Dose-Painting for IGRT Medical Physics. 37: 3437-3438. DOI: 10.1118/1.3469432 |
0.718 |
|
| 2010 |
Cormack R, Nguyen P, D”Amico A, Sridhar S, Makrigiorgos M. MO‐FF‐A1‐01: Optimal Schedule for Localized Radio‐Sensitization of 125I Prostate Implants Medical Physics. 37: 3361-3361. DOI: 10.1118/1.3469137 |
0.33 |
|
| 2010 |
Casse BDF, Lu WT, Huang YJ, Gultepe E, Menon L, Sridhar S. Super-resolution imaging using a three-dimensional metamaterials nanolens Applied Physics Letters. 96: 023114. DOI: 10.1063/1.3291677 |
0.77 |
|
| 2010 |
Cormack RA, Nagesha D, Gultepe E, Nguyen P, D'Amico AV, Sridhar S, Makrigiorgos M. Drug Eluting Brachytherapy Spacers: A Potential for Biologically-Enhanced Brachytherapy Brachytherapy. 9: S48-S49. DOI: 10.1016/J.Brachy.2010.02.065 |
0.767 |
|
| 2009 |
Casse BD, Lu WT, Banyal RK, Huang YJ, Selvarasah S, Dokmeci MR, Perry CH, Sridhar S. Imaging with subwavelength resolution by a generalized superlens at infrared wavelengths. Optics Letters. 34: 1994-6. PMID 19571977 DOI: 10.1364/Ol.34.001994 |
0.631 |
|
| 2009 |
Casse BD, Lu WT, Huang Y, Sridhar S. Metallic Nanolens and III-V Nano-Optical Metamaterials Lenses for Subwavelength Imaging and Optoelectronics Applications Energy. DOI: 10.1364/Energy.2009.Thc4 |
0.627 |
|
| 2009 |
Cormack R, Sridhar S, Nagesha D, Gultepe E, Suh W, D'Amico A, Makrigiorgos M. TH-D-210A-06: Drug Eluting Implanted Devices to Increase Biologic Effective Dose in Image Guided Radiation Therapy Medical Physics. 36: 2819-2819. DOI: 10.1118/1.3182708 |
0.783 |
|
| 2009 |
Nagesha DK, Plouffe BD, Phan M, Lewis LH, Sridhar S, Murthy SK. Functionalization-induced improvement in magnetic properties of Fe3 O4 nanoparticles for biomedical applications Journal of Applied Physics. 105. DOI: 10.1063/1.3073654 |
0.692 |
|
| 2009 |
Sawant RM, Sawant RR, Gultepe E, Nagesha D, Papahadjopoulos-Sternberg B, Sridhar S, Torchilin VP. Nanosized cancer cell-targeted polymeric immunomicelles loaded with superparamagnetic iron oxide nanoparticles Journal of Nanoparticle Research. 11: 1777-1785. DOI: 10.1007/S11051-009-9611-4 |
0.784 |
|
| 2008 |
Gultepe E, Nagesha D, Casse BD, Selvarasah S, Busnaina A, Sridhar S. Large scale 3D vertical assembly of single-wall carbon nanotubes at ambient temperatures. Nanotechnology. 19: 455309. PMID 21832774 DOI: 10.1088/0957-4484/19/45/455309 |
0.749 |
|
| 2008 |
Lu WT, Sridhar S. Superlens imaging theory for anisotropic nanostructured metamaterials with broadband all-angle negative refraction Physical Review B - Condensed Matter and Materials Physics. 77. DOI: 10.1103/Physrevb.77.233101 |
0.32 |
|
| 2008 |
Menon L, Lu WT, Friedman AL, Bennett SP, Heiman D, Sridhar S. Negative index metamaterials based on metal-dielectric nanocomposites for imaging applications Applied Physics Letters. 93. DOI: 10.1063/1.2945647 |
0.322 |
|
| 2007 |
Lu WT, Huang YJ, Vodo P, Banyal RK, Perry CH, Sridhar S. A new mechanism for negative refraction and focusing using selective diffraction from surface corrugation. Optics Express. 15: 9166-75. PMID 19547258 DOI: 10.1364/Oe.15.009166 |
0.622 |
|
| 2007 |
Gultepe E, Nagesha D, Menon L, Busnaina A, Sridhar S. High-throughput assembly of nanoelements in nanoporous alumina templates Applied Physics Letters. 90: 163119. DOI: 10.1063/1.2730575 |
0.765 |
|
| 2006 |
Shenoy D, Fu W, Li J, Crasto C, Jones G, DiMarzio C, Sridhar S, Amiji M. Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery. International Journal of Nanomedicine. 1: 51-7. PMID 16467923 DOI: 10.2147/Nano.2006.1.1.51 |
0.347 |
|
| 2005 |
Lu WT, Sridhar S. Flat lens without optical axis: Theory of imaging. Optics Express. 13: 10673-80. PMID 19503282 DOI: 10.1364/Opex.13.010673 |
0.306 |
|
| 2005 |
Li J, Crasto CF, Weinberg JS, Amiji M, Shenoy D, Sridhar S, Bubley GJ, Jones GB. An approach to heterobifunctional poly(ethyleneglycol) bioconjugates. Bioorganic & Medicinal Chemistry Letters. 15: 5558-61. PMID 16236512 DOI: 10.1016/J.Bmcl.2005.08.108 |
0.329 |
|
| 2005 |
Sridhar S, Parimi PV, Lu WT, Vodo P, Derov JS. Imaging and negative refraction in left-handed metamaterials Metamaterials. 5955: 595505. DOI: 10.1117/12.623051 |
0.308 |
|
| 2004 |
Fu W, Shenoy D, Li J, Crasto C, Jones G, Dimarzio C, Sridhar S, Amiji M. Biomedical Applications of Gold Nanoparticles Functionalized Using Hetero-Bifunctional Poly(ethylene glycol) Spacer Mrs Proceedings. 845. DOI: 10.1557/Proc-845-Aa5.4 |
0.338 |
|
| 2003 |
Parimi PV, Lu WT, Vodo P, Sridhar S. Photonic crystals: imaging by flat lens using negative refraction. Nature. 426: 404. PMID 14647372 DOI: 10.1038/426404A |
0.305 |
|
| Show low-probability matches. |